Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-13

Clinical Trial Update: AMG 151 Amgen Protocol Number 20100761 [Phase 2]

View source ↗

Summary

Amgen reports that the Phase 2 study of AMG 151 (protocol 20100761) for Diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMG 151

Snippet

Sponsor: Amgen | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED